Research programme: dopamine modulators - Integrative Research Laboratories
Alternative Names: P003; P003 projectLatest Information Update: 28 Jan 2025
At a glance
- Originator Integrative Research Laboratories
- Class Antiparkinsonians
- Mechanism of Action Dopamine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Jan 2025 No recent reports of development identified for research development in Parkinson's-disease in Sweden
- 19 Jan 2023 Research development in Parkinson's-diseaseis is ongoing in Sweden (Integrative Research Laboratories website, January 2023)
- 28 Oct 2022 No recent reports of development identified for research development in Parkinson's-disease in Sweden